Caxton Associates (UK)’s Madison Square Garden MSGS Stock Holding History
Bought
Maintained
Sold
Other funds holding MSGS
SLG
AI
GI
Caxton Associates (UK)'s MSGS Position: Q1 2026 in Review
Caxton Associates (UK) sold out of Madison Square Garden (MSGS) in Q1 2026, closing a stake of 1,180 shares — an estimated $305K sold.
Caxton Associates (UK) first reported a position in MSGS in Q2 2025 and held it in 2 quarters. The position peaked at $305K in Q4 2025. 410 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.
- Caxton Associates (UK) reported no remaining Madison Square Garden position as of Q1 2026 after selling out during the quarter.
- Caxton Associates (UK) sold 1,180 Madison Square Garden shares in Q1 2026, an estimated $305K.
- Caxton Associates (UK) first reported a position in Madison Square Garden in Q2 2025 and held it in 2 quarters.
- Caxton Associates (UK)'s Madison Square Garden position peaked at $305K in Q4 2025.
- 410 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.
Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.